TransMedics Group

YTD

ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform.

CEO

Waleed H. Hassanein

CEOWaleed H. Hassanein

Employees

728

Employees728

Headquarters

Andover, Massachusetts

HeadquartersAndover, Massachusetts

Founded

1998

Founded1998

Employees

728

Employees728

TMDX Key Statistics

Market cap

3.89B

Market cap3.89B

Price-Earnings ratio

59.24

Price-Earnings ratio59.24

Dividend yield

—

Dividend yield—

Average volume

1.22M

Average volume1.22M

High today

$117.24

High today$117.24

Low today

$113.01

Low today$113.01

Open price

$114.84

Open price$114.84

Volume

676.36K

Volume676.36K

52 Week high

$169.29

52 Week high$169.29

52 Week low

$55.00

52 Week low$55.00

TMDX News

Simply Wall St 2d

TransMedics Group Is Up 10.1% After Analysts Upgrade Earnings Estimates for Fiscal 2025 – What's Changed

Earlier this week, TransMedics Group saw four analysts revise their earnings estimates upward for fiscal 2025, boosting the consensus outlook for both earnings...

TipRanks 7d

Balanced Outlook on TransMedics Group: Ambitious Growth Amidst Market Challenges

TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Patrick Wood from Morgan Stanley maintained a Hold r...

Analyst ratings

64%

of 11 ratings

Buy

63.6%

Hold

36.4%

Sell

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Hims & Hers Health

Rocket Lab Corporation